Well-informed intermediaries in strategic communication

Economic Inquiry

Volumn 50, Issue 2, 2012, Pages 380-398

  Li, Wei ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84859731708     PISSN: 00952583     EISSN: 14657295     Source Type: Journal    
DOI: 10.1111/j.1465-7295.2010.00306.x     Document Type: Article

References (26)

1. Austen-Smith, D. "Information Transmission in Debate." American Journal of Political Science, 34(1), 1990, 124-52.
2. Avorn, J., M. Chen, and R. Hartley. "Scientific versus Commercial Sources of Influence on the Prescribing Behavior of Physicians." American Journal of Medicine, 73(1), 1982, 4-8.
3. Bandler, J. "Advice for Sale: How Companies Pay TV Experts for On-Air Product Mentions." Wall Street Journal, 19 April 2005, p. A1.
4. Brennan, T. A., D. J. Rothman, L. Blank, D. Blumenthal, S. C. Chimonas, J. J. Cohen, J. Golden, J. P. Kassirer, H. Kimball, J. Naughton, and N. H. Smelser. "Health Industry Practices That Create Conflicts of Interest: A Policy Proposal for Academic Medical Centers." Journal of the American Medical Association, 295(4), 2006, 429-33.
5. Carey, B. "Study Finds a Link of Drug Makers to Psychiatrists." New York Times, 20 April 2006. Available at:.
6. Chan, W., H. Li, and W. Suen. "A Signaling Theory of Grade Inflation." International Economic Review, 48(7), 2007, 1065-90.
7. Crawford, V. P., and J. Sobel. "Strategic Information Transmission." Econometrica, 50(6), 1982, 1431-51.
8. Dewatripont, M., and J. Tirole. "Advocates." Journal of Political Economy, 107, 1999, 1-39.
9. Durbin, E., and G. Iyer. "Corruptible Advice." American Economic Journal: Microeconomics, 1(2), 2009, 220-42.
10. Gerardi, D., R. Mclean, and A. Postlewaite. "Aggregation of Expert Opinions." Games and Economic Behavior, 65(2), 2009, 339-71.
11. Inderst, R., and M. Ottaviani. "Misselling through Agents." American Economic Review, 99(3), 2009, 883-908.
12. Kassirer, JP. "How Drug Lobbyists Influence Doctors." Boston Globe, 13 February 2006. Available at:.
13. Levy, G. "Anti-Herding and Strategic Consultation." European Economic Review, 48(3), 2004, 503-25.
14. Levy, G. "Decision Making in Committees: Transparency, Reputation and Voting Rules." American Economic Review, 97(1), 2007, 150-68.
15. Li, W. "Changing One's Mind when the Facts Change: Incentives of Experts and the Design of Reporting Protocols." Review of Economic Studies, 74(4), 2007, 1175-94.
16. Li, W. Forthcoming. "Peddling Influence through Intermediaries." American Economic Review.
17. Morris, S. "Political Correctness." Journal of Political Economy, 109(2), 2001, 231-65.
18. New York Times. "Evidence in Vioxx Suits Shows Intervention by Merck Officials." New York Times, 24 April 2005.
19. Ottaviani, M., and P. Sorensen. "Professional Advice." Journal of Economic Theory, 126(1), 2006a, 120-42.
20. Ottaviani, M., and P. Sorensen. "Reputational Cheap Talk." Rand Journal of Economics, 37(1), 2006b, 155-75.
21. Prat, A. "The Wrong Kind of Transparency." American Economic Review, 95(3), 2005, 862-77.
22. Prendergast, C. "A Theory of 'Yes Men'." American Economic Review, 83(4), 1993, 757-70.
23. Prendergast, C., and L. Stole. "Impetuous Youngsters and Jaded Old-Timers: Acquiring a Reputation for Learning." Journal of Political Economy, 104(6), 1996, 1105-34.
24. Saul, S. "Unease on Industry's Role in Hypertension Debate." New York Times, 20 May 2006. Available at:.
25. Scharfstein, D. S., and J. C. Stein. "Herd Behavior and Investment." American Economic Review, 80(3), 1990, 465-79.
26. Watkins, C., L. Moore, I. Harvey, P. Carthy, E. Robinson, and R. Brawn. "Characteristics of General Practitioners Who Frequently See Drug Industry Representatives: One National Cross Sectional Survey." British Medical Journal, 326, 2003, 1178-79.